Health

Samsung Biologics Reports Third Quarter 2022 Financial Results

* Recorded consolidated revenue of KRW 873 billion in Q3'22 * Recorded consolidated operating profit of KRW 324.7 billion in Q3'22 * Started partial operations at Plant 4 within 23 months since groundbreaking as previously committed and launched two new development platforms INCHEON, South K...

2022-10-27 07:35 2063

Waterdrop Opens Its First Community outlet in Shenzhen to Explore the "Insurance + Community" Model

BEIJING, Oct. 26, 2022 /PRNewswire/ -- Waterdrop recently opened its first independent personal insurance agent-based community outlet inShenzhen, which is the first outlet that cooperates with community healthcare centers on insurance service. Critical to Shenzhen's medical service system, comm...

2022-10-26 22:00 2945

Lunit Joins World Economic Forum Global Innovators Community

* Lunit invited to join the World Economic Forum's Global Innovators Community, an invitation-only group of the world's most promising start-ups and scale-ups at the forefront of technological and business model innovation * In 2020, Lunit was nominated among hundreds of candidates as one of t...

2022-10-26 21:00 2547

Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting

MELBOURNE, Australia and SAN FRANCISCO , Oct. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced a poster presentation f...

2022-10-26 19:25 2151

WuXi AppTec Reports Record Year-to-Date Results in 2022, Third Quarter Revenue over RMB10 Billion

Revenue Up 71.9% Year-Over-Year to RMB28,395 Million Net Profit Attributable to Owners of the Company Up 107.1% Year-Over-Year to RMB7,378 Million Diluted Earnings Per Share (EPS) Up 90.1% Year-Over-Year to RMB2.30 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 77.9% Year...

2022-10-26 19:06 3414

Meet the female scientists who develop cellular and gene therapies

SHENZHEN, China, Oct. 26, 2022 /PRNewswire/ -- Inside Namtai Inno Park in Guangming District hides a low-profile biomedical development firm – Shenzhen Wingor Biotechnology Co. Upon entering the company, one may feel a different vibe – something gentle yet vibrant, maybe because it's female-domin...

2022-10-26 17:07 2101

Yiling Pharmaceutical Exhibiting its Innovative TCM Products during CHEXPO Macau 2022

SHIJIAZHUANG, China, Oct. 26, 2022 /PRNewswire/ -- CHEXPO Macau 2022 was officially opened onOctober 20, 2022. As one of the top 10 TCM enterprises in China, Yiling Pharmaceutical exhibited a number of its patented TCM and health products during the expo. As an international and frontier city of ...

2022-10-26 16:52 2020

'SWESD 2022,' The Joint World Conference on Social Work, Education and Social Development to be held in Seoul for four days starting 26th Oct.

SEOUL, South Korea, Oct. 26, 2022  /PRNewswire/ -- "SWESD 2022," The Joint World Conference on Social Work, Education and Social Development will be held for four days starting fromOctober 26.

2022-10-26 14:46 1716

ImmVira announced its signing of Series C+ financing and negotiation with further investors for the round

SHENZHEN, China, Oct. 26, 2022 /PRNewswire/ -- ImmVira announced its successful signing of Series-C+ financing transaction documents with the first batch of investors recently. This round of financing was initiated by China Merchants China Direct Investments Limited with participation of Lifebay ...

2022-10-26 14:26 2021

WuXi Biologics Announces GMP Release of 48,000L Commercial Drug Substance Manufacturing Facility in Hebei, China

-  The 11th drug substance facility is released for cGMP operation in the WuXi Biologics' global manufacturing network. This new facility enhances the company's capability of providing commercial manufacturing at 4,000L to 20,000L scale, facilitating any project initiation within four weeks. -  ...

2022-10-26 12:30 2111

Alwin Capital's New Dual-Currency Fund Closed and Exceeded Fundraising Target

BEIJING, Oct. 25, 2022 /PRNewswire/ -- Alwin Capital recently closed a new dual-currency fund, raising overUS$300 million, which exceeds their fundraising target. The RMB investors of this new dual-currency fund ...

2022-10-25 23:10 2098

SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines

* CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available for late-stage development. * SK bioscience to secure new vaccines and establish pandemic response system * SK bioscience to enhance human healt...

2022-10-25 20:00 2257

FDA Accepts NMP's Clinical Trial Application for Development of NMK89 as Imaging Agent for Cancer Diagnosis

 - Clinical Study Set to Begin, Focusing on Diagnostic Use of Theranostics - TOKYO, Oct. 25, 2022 /PRNewswire/ -- Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company inJapan, is pleased to announce that the U.S. Food and Drug Administration (FDA) has recently accepted NMP's ...

2022-10-25 16:00 1683

ReviR Therapeutics Expands Research Team by Appointing Dr. Sridhar Narayan as Head of Medicinal Chemistry

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2022 /PRNewswire/ -- ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, recently announced the appointment of Dr.Sridhar Narayan as Vice President responsible for the global Medicinal Chemistry team. "I am d...

2022-10-24 22:00 2562

Waterdrop Explores Offline Insurance Brokerage

BEIJING, Oct. 24, 2022 /PRNewswire/ -- Since 2022, Waterdrop has stepped up offline brokerage, and offered offline brokers with multiple development directions including organization development mode, independent agent mode, and community outlet mode, in an effort to build an elite service team. ...

2022-10-24 21:30 3629

Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Oct. 24, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment o...

2022-10-24 21:00 2677

Ping An Health acquires Ping An Smart Healthcare

Harnessing synergies to empower Ping An's managed care business model HONG KONG and SHANGHAI, Oct. 24, 2022 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or "Ping An Health"; Stock Code: 1833.HK), announced the acquisition of Ping An Smart Healthcare, a...

2022-10-24 16:26 3075

United Imaging Healthcare Attends European Association of Nuclear Medicine Congress With uEXPLORER®, The World's First Total-Body PET/CT

* To provide tailored, precise solutions and bring the value of molecular imaging to patient care BARCELONA, Spain, Oct. 24, 2022 /PRNewswire/ -- United Imaging Healthcare (UIH), a global innovator in advanced medical imaging, debuts at the European Association of Nuclear Medicine (EANM) Congre...

2022-10-24 15:13 1794

WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities

* WuXi Biologics adds further capacity and capability for drug product fill & finish, providing global customers with end-to-end integrated solutions for diversified modalities, including mRNA-LNP HANGZHOU, China, Oct. 23, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading gl...

2022-10-24 08:30 2047

SK bioscience Appoints New Executives towards Global Business Growth

* Global experts continue to join SK bioscience, while its U.S. corporate entity is being established * Company plans to strategically invest in personnel, innovation & infrastructure to ensure global competitiveness SEOUL, South Korea, Oct. 21, 2022 /PRNewswire/ -- SK bioscience, a global in...

2022-10-21 20:00 2509
1 ... 132133134135136137138 ... 280